About IMI
 

Home

News

24.08.2015

DisGeNET has just announced their latest RDF release, including:

Read more...

04.08.2015

OPS.js is a JavaScript library you can use to fetch and parse responses from the Open PHACTS API. It is now available via the Node Package Manager which means that anyone using Node-based JavaScript applications can easily include it. It is also available as a single file download for standard JavaScript applications. More details can be found on GitHub. OPS.js is used in the Open PHACTS Explorer and in the BioJS Open PHACTS compound widget.


27.07.2015

Biological patent annotations are now displayed on the SureChEMBL interface. In collaboration with Open PHACTS and SciBite, the EBI have implemented a mechanism to allow users to highlight biological entities (such as genes and diseases) within SureChEMBL patent documents. For more information see the SureChEMBL blog.

Read more...

24.07.2015

We are pleased to announce the release of version 1.5 of the Open PHACTS component collection. There are no major changes to the components, but this version is needed to connect to version 1.5 of the Open PHACTS API, which has refreshed data and several other improvements.

Download version 1.5 of the Open PHACTS Pipeline Pilot components


24.07.2015

ChemBioNavigator is a web application that was specifically designed to visualise the small-molecule and pharmacological data integrated by Open PHACTS. Last week BioSolveIT hosted a webinar showing how ChemBioNavigator can be used to:

Read more...

The Open PHACTS Discovery Platform has been developed to reduce barriers to drug discovery in industry, academia and for small businesses. You can now access the integrated pharmacological data via the Open PHACTS API, Open PHACTS Explorer or apps

 

 “Open PHACTS is enabling you to do what you do best!”

 

 

The Open PHACTS project has received support from the Innovative Medicines Initiative Joint Undertaking under grant agreement n° 115191, resources of which are composed of financial contribution from the European Unions's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies' in kind contribution.

This website reflects only the author's views and neither IMI nor the European Commission is liable for any use that may be made of the information contained therein.

Upcoming Events

Conferences:

 

September 12-14, 2015
24th Scientific Congress of the Austrian Pharmaceutical Society in Vienna, Austria

 

September 22-25, 2015
Ambient Assisted Living Forum in Ghent, Belgium

 

Project Meetings:  

 

October 7-8, 2015
Open PHACTS Consortium Meeting at Lilly, UK

 

February 18-19, 2016
Open PHACTS Project Closing Meeting in Vienna, Austria

 

IMI

 

EU EFPIA